36
IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA LETTERATURA ROBERTO CESAREO LATINA

IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

IL NODULO TIROIDEO IPERFUNZIONANTE

MIT: EVIDENZE DELLA LETTERATURA

ROBERTO CESAREO

LATINA

Page 2: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Progressively growing benign, thyroid lesions that reach to a volume over 12 ml seem to be especially suited for minimally invasive procedures.

Less appropriate indications are large nodular goitres, multinodular thyroid disease or deeply positioned lesions.

European Journal of Endocrinology (2014)

Page 3: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

VOLUME 20X18X21 = 4,1 ml

VOLUME 2.8X2.8X3.2 = 13 ml

VOLUME THYROID NODULE

NODULO SMALL

NODULO MIDDLE

NODULO LARGE

VOLUME 46X34X46 = 37 ml

Nodulo small <12 ml

Nodulo Middle 12 e 30ml

Nodulo Large >30 ml

VOLUMETRIC CLASSIFICATION

Page 4: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

For patients with toxic adenoma, the risk of

treatment failure is < 1% after surgical resection

(ipsilateral thyroid lobectomy or isthmusectomy)

The prevalence of hypothyroidism is 2.3% following

lobectomy for toxic adenoma

Page 5: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Postradioiodine hypothyroidism may develop in up to 60% after

20 years

However, radioiodine is not suited for large nodules that

require high doses of radioiodine and may be unresponsive to

treatment

ENDOCRINE PRACTICE 2010

Page 6: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Int J Endocrinol Metab. 2014

Page 7: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Patients with end-stage renal failure cannot excrete radioiodine normally

Breast feeding

Pregnancy

Drugs with a high iodine content (amiodarone, saturated solution of potassium iodide or radiocontrast media)

Claustrophobic patients

RADIOIODINE TREATMENT

Exclusion Criteria

Page 8: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

THYROID 2017

Long-term ATD treatment is effective and safe, especially in adults,

indicating that it should be considered as an alternative treatment for

Graves’ disease.

Page 9: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

LASER THERMAL ABLATION

Page 10: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

RADIOFREQUENCY

MOVING SHOT AND HOOK UMBRELLA

Page 11: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

ENDOCRINE PRACTICE Vol 22 No. 5 May 2016

Page 12: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

ENDOCRINE PRACTICE Vol 22 No. 5 May 2016

Page 13: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Endocr Pract 2007

The total number of PLA sessions

ranged from 1 to 5 (median, 3)

Page 14: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Combined treatment determined faster volume reduction and relief of symptoms, and faster control of hyperthyroidism.

In group (LAT131I), however, normalization of TSH occurred in nine of 15 patients (60%) already 1 month after LAT; in particular, in three of these patients radioiodine was not necessary

J Clin Endocrinol Metab 2014

Page 15: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Int J Hypert 2017

Page 16: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Endocrine 2015

The patients that went into remission had their

nodules reduced on average by 81 %, as compared

to those that improved, which were reduced on average

by 68% after 12 months from the procedure

Page 17: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

The mean number

of treatment session was

1.8 ± 0.9

(range, 1 - 6 sessions))

Thyroid 2015

Page 18: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Int J Hypert 2018

Page 19: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Int J Hyper2018

Page 20: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Scintigrafia_t0 scintigrafia_t24

hot coldDrop-

out hot cold

VOLUME NODULO

<1215 0 1 2 12

>1214 0 3 9 2

Page 21: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Int J Hypert 2018

Page 22: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Clin End 2019

Page 23: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment
Page 24: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

UNDER REVISION 2019

Page 25: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Under Rev 2019

Page 26: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Under Rev 2019

Page 27: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Under Rev 2019

Page 28: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Under Rev 2019

Page 29: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment
Page 30: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Korean J Radiol 2018

Page 31: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

Int J Hypert 2019

Page 32: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment
Page 33: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment
Page 34: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

TAKE HOME MESSAGES

Strong evidences

⚫ Toxic or pre-toxic thyroid nodule < 5/10 ml

⚫ The patient refuses surgery or cannot do

surgery or RM treatment

⚫ THY-2 at citological examination

Page 35: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment

⚫ Nodule > 20 ml: what should we do?

⚫ Is it cost-effective to performe more

treatments?

⚫ More of these nodules are THY 3a:

What shall we do in this context?

TAKE HOME MESSAGES

Low evidences

Page 36: IL NODULO TIROIDEO IPERFUNZIONANTE MIT: EVIDENZE DELLA …termoablazionetiroide.it/presentazioni/06.pdf · 2019. 2. 19. · For patients with toxic adenoma, the risk of treatment